| Literature DB >> 34343321 |
Máire A Conrad1,2, Judith R Kelsen1,2.
Abstract
Clostridioides difficile infection (CDI) in children with inflammatory bowel disease (IBD) can present and manifest differently from the general population with CDI, and it can worsen the underlying disease course. Furthermore, current clinical assays used to test for CDI do not accurately distinguish between true CDI or colonization. This uncertainty leads to difficulty in identifying the etiology and therapy for symptomatic patients with IBD. Improved diagnostic tests, biomarkers, and safe and effective treatment options are greatly needed for this vulnerable population.Entities:
Keywords: Clostridioides difficile infection; fecal microbiota transplant; inflammatory bowel disease; pediatric
Mesh:
Year: 2021 PMID: 34343321 PMCID: PMC8600020 DOI: 10.1093/jpids/piab069
Source DB: PubMed Journal: J Pediatric Infect Dis Soc ISSN: 2048-7193 Impact factor: 5.235